Related Experiment Video
Updated: Dec 21, 2025

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Epidemiology and survival outcomes in stages II and III cutaneous melanoma: a systematic review
Rachael Miller1, Sophie Walker1, Irene Shui2
1PHMR Ltd, Berkeley Works, Berkley Grove, Camden Town, London, UK.
Aim:
Management of cutaneous melanoma (CM) is continually evolving with adjuvant treatment of earlier stage disease. The aim of this review was to identify published epidemiological data for stages II-III CM.
Materials & Methods:
Systematic searches of Medline and Embase were conducted to identify literature reporting country/region-specific incidence, prevalence, survival or mortality outcomes in stage II and/or III CM. Screening was carried out by two independent reviewers.
Results & Conclusion:
Of 41 publications, 14 described incidence outcomes (incidence rates per stage were only reported for US and Swedish studies), 33 reported survival or mortality outcomes and none reported prevalence data. This review summarizes relevant data from published literature and highlights an overall paucity of epidemiological data in stages II and III CM.
Related Concept Videos
Cancer Survival Analysis
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Comparing the Survival Analysis of Two or More Groups
Kaplan-Meier Approach
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Assumptions of Survival Analysis

